Validation of erythropoietin use data on Medicare's End-Stage Renal Disease Medical Evidence Report.
about
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.Effects of prosthetic limb prescription on 3-year mortality among Veterans with lower-limb amputation.Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease.ESRD Databases, Public Policy, and Quality of Care: Translational Medicine and Nephrology.
P2860
Validation of erythropoietin use data on Medicare's End-Stage Renal Disease Medical Evidence Report.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Validation of erythropoietin u ...... sease Medical Evidence Report.
@ast
Validation of erythropoietin u ...... sease Medical Evidence Report.
@en
type
label
Validation of erythropoietin u ...... sease Medical Evidence Report.
@ast
Validation of erythropoietin u ...... sease Medical Evidence Report.
@en
prefLabel
Validation of erythropoietin u ...... sease Medical Evidence Report.
@ast
Validation of erythropoietin u ...... sease Medical Evidence Report.
@en
P2093
P1476
Validation of erythropoietin u ...... isease Medical Evidence Report
@en
P2093
Ann M O'Hare
Denise M Hynes
James S Kaufman
Kevin T Stroupe
Margaret M Browning
Michael J Fischer
Min-Woong Sohn
Pierre Blemur
Zhiping Huo
P304
P356
10.1682/JRRD.2009.08.0108
P577
2010-01-01T00:00:00Z